Clene Inc. (CLNNW) Financials

CLNNW Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 52.3 million 39.0 million
2023-09-30 60.4 million 39.0 million
2023-06-30 67.8 million 46.3 million
2023-03-31 39.9 million 41.5 million

CLNNW Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -7.3 million 2.0 million
2023-09-30 -6.8 million 2.4 million
2023-06-30 -7.0 million 2.5 million
2023-03-31 -9.5 million 2.2 million

CLNNW Net Income

No data available :(

CLNNW Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 35.0 million - 5.5 million
2023-09-30 42.1 million - 5.7 million
2023-06-30 49.2 million 16.0 million 5.8 million
2023-03-31 18.4 million - 6.0 million

CLNNW Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 128.4 million
2023-09-30 128.4 million
2023-06-30 86.1 million
2023-03-31 76.0 million

CLNNW Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 43445 6.3 million 3.3 million 43000
2023-09-30 48000 6.0 million 3.7 million -
2023-06-30 39000 6.6 million 3.5 million -
2023-03-31 278000 7.4 million 3.2 million -

CLNNW Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 170000 460000
2023-09-30 108000 12000
2023-06-30 269000 66000
2023-03-31 107000 5000

CLNNW

Price: $0.04

52 week price:
0.04
0.07

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 590

Market Capitalization: 647.0 million

Links: